Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors

Background/Aim: A number of biologically active substances were proved as an alternative to conventional anticancer medicines. The aim of the study is in vitro investigation of the anticancer activity of mono- and di-Rhamnolipids (RL-1 and RL-2) against human breast cancer. Additionally, the combina...

Full description

Bibliographic Details
Main Authors: Severina Semkova, Georgi Antov, Ivan Iliev, Iana Tsoneva, Pavel Lefterov, Nelly Christova, Lilyana Nacheva, Ivanka Stoineva, Lyudmila Kabaivanova, Galya Staneva, Biliana Nikolova
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Separations
Subjects:
Online Access:https://www.mdpi.com/2297-8739/8/7/92
_version_ 1827688603130527744
author Severina Semkova
Georgi Antov
Ivan Iliev
Iana Tsoneva
Pavel Lefterov
Nelly Christova
Lilyana Nacheva
Ivanka Stoineva
Lyudmila Kabaivanova
Galya Staneva
Biliana Nikolova
author_facet Severina Semkova
Georgi Antov
Ivan Iliev
Iana Tsoneva
Pavel Lefterov
Nelly Christova
Lilyana Nacheva
Ivanka Stoineva
Lyudmila Kabaivanova
Galya Staneva
Biliana Nikolova
author_sort Severina Semkova
collection DOAJ
description Background/Aim: A number of biologically active substances were proved as an alternative to conventional anticancer medicines. The aim of the study is in vitro investigation of the anticancer activity of mono- and di-Rhamnolipids (RL-1 and RL-2) against human breast cancer. Additionally, the combination with Cisplatin was analyzed. Materials and Methods: Breast cell lines (MCF-10A, MCF-7 and MDA-MB-231) were treated with RLs and in combination with Cisplatin. The viability was analyzed using MTT assay, and investigation of autophagy was performed via acridine orange staining. Results: In contrast to the healthy cells, both tested cancer lines exhibited sensitivity to RLs treatment. This effect was accompanied by an influence on the autophagy-related acidic formation process. Only for the triple-negative breast cancer cell line (MDA-MB-231) the synergistic effect of the combined treatment (10 µM Cisplatin and 1 µg/mL RL-2) was observed. Conclusion: Based on studies on the reorganization of membrane models in the presence of RL and the data about a higher amount of lipid rafts in cancer cell membranes than in non-tumorigenic, we suggest a possible mechanism of membrane remodelling by formation of endosomes. Shortly, in order to have a synergistic effect, it is necessary to have Cisplatin andRL-2 as RL2 is a molecule inducingpositive membrane curvature.
first_indexed 2024-03-10T10:00:02Z
format Article
id doaj.art-d1357908b2194463a67cca1a0895e951
institution Directory Open Access Journal
issn 2297-8739
language English
last_indexed 2024-03-10T10:00:02Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Separations
spelling doaj.art-d1357908b2194463a67cca1a0895e9512023-11-22T02:04:27ZengMDPI AGSeparations2297-87392021-06-01879210.3390/separations8070092Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy InhibitorsSeverina Semkova0Georgi Antov1Ivan Iliev2Iana Tsoneva3Pavel Lefterov4Nelly Christova5Lilyana Nacheva6Ivanka Stoineva7Lyudmila Kabaivanova8Galya Staneva9Biliana Nikolova10Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaFaculty of Educational Studies and the Arts University of Sofia, Bul. Shipchenski Prohod, 1113 Sofia, BulgariaThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 26, 1113 Sofia, BulgariaThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 26, 1113 Sofia, BulgariaInstitute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 9, 1113 Sofia, BulgariaThe Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 26, 1113 Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaInstitute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, “Acad. G. Bonchev” Str., Bl. 21, 1113 Sofia, BulgariaBackground/Aim: A number of biologically active substances were proved as an alternative to conventional anticancer medicines. The aim of the study is in vitro investigation of the anticancer activity of mono- and di-Rhamnolipids (RL-1 and RL-2) against human breast cancer. Additionally, the combination with Cisplatin was analyzed. Materials and Methods: Breast cell lines (MCF-10A, MCF-7 and MDA-MB-231) were treated with RLs and in combination with Cisplatin. The viability was analyzed using MTT assay, and investigation of autophagy was performed via acridine orange staining. Results: In contrast to the healthy cells, both tested cancer lines exhibited sensitivity to RLs treatment. This effect was accompanied by an influence on the autophagy-related acidic formation process. Only for the triple-negative breast cancer cell line (MDA-MB-231) the synergistic effect of the combined treatment (10 µM Cisplatin and 1 µg/mL RL-2) was observed. Conclusion: Based on studies on the reorganization of membrane models in the presence of RL and the data about a higher amount of lipid rafts in cancer cell membranes than in non-tumorigenic, we suggest a possible mechanism of membrane remodelling by formation of endosomes. Shortly, in order to have a synergistic effect, it is necessary to have Cisplatin andRL-2 as RL2 is a molecule inducingpositive membrane curvature.https://www.mdpi.com/2297-8739/8/7/92bacterial natural rhamnolipidsbreast cancerautophagycytotoxitymembrane reorganizationendocytosis
spellingShingle Severina Semkova
Georgi Antov
Ivan Iliev
Iana Tsoneva
Pavel Lefterov
Nelly Christova
Lilyana Nacheva
Ivanka Stoineva
Lyudmila Kabaivanova
Galya Staneva
Biliana Nikolova
Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
Separations
bacterial natural rhamnolipids
breast cancer
autophagy
cytotoxity
membrane reorganization
endocytosis
title Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
title_full Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
title_fullStr Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
title_full_unstemmed Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
title_short Rhamnolipid Biosurfactants—Possible Natural Anticancer Agents and Autophagy Inhibitors
title_sort rhamnolipid biosurfactants possible natural anticancer agents and autophagy inhibitors
topic bacterial natural rhamnolipids
breast cancer
autophagy
cytotoxity
membrane reorganization
endocytosis
url https://www.mdpi.com/2297-8739/8/7/92
work_keys_str_mv AT severinasemkova rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT georgiantov rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT ivaniliev rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT ianatsoneva rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT pavellefterov rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT nellychristova rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT lilyananacheva rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT ivankastoineva rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT lyudmilakabaivanova rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT galyastaneva rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors
AT biliananikolova rhamnolipidbiosurfactantspossiblenaturalanticanceragentsandautophagyinhibitors